| __timestamp | PTC Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 3243000 |
| Thursday, January 1, 2015 | 121816000 | 2472000 |
| Friday, January 1, 2016 | 117633000 | 2548000 |
| Sunday, January 1, 2017 | 4577000 | 19623000 |
| Monday, January 1, 2018 | 12670000 | 30421000 |
| Tuesday, January 1, 2019 | 12135000 | 32793999 |
| Wednesday, January 1, 2020 | 18942000 | 28304000 |
| Friday, January 1, 2021 | 32328000 | 620000 |
| Saturday, January 1, 2022 | 44678000 | 755000 |
| Sunday, January 1, 2023 | 65486000 | 1322000 |
Data in motion
In the ever-evolving biotech industry, understanding cost structures is crucial for assessing company performance. This analysis delves into the cost of revenue trends for PTC Therapeutics, Inc. and Viridian Therapeutics, Inc. from 2014 to 2023.
PTC Therapeutics, Inc. has seen a fluctuating cost of revenue, peaking in 2015 with a 150% increase from the previous year, followed by a significant drop in 2017. However, the company has shown resilience, with costs rising steadily by 40% from 2021 to 2023.
Conversely, Viridian Therapeutics, Inc. experienced a dramatic rise in costs in 2017, reaching a peak in 2019. Despite a sharp decline in 2021, the company has managed to stabilize its costs, albeit at a lower level.
These insights highlight the dynamic nature of cost management in the biotech sector, offering valuable lessons for investors and industry stakeholders.
Cost of Revenue Trends: Pfizer Inc. vs PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for GSK plc and Viridian Therapeutics, Inc.
Cost of Revenue Trends: United Therapeutics Corporation vs PTC Therapeutics, Inc.
Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Halozyme Therapeutics, Inc. and PTC Therapeutics, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Dyne Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.